<DOC>
	<DOCNO>NCT01138488</DOCNO>
	<brief_summary>This trial conduct Europe . The aim study investigate total exposure NN5401 ( insulin degludec/insulin aspart ) child , adolescent adult subject type 1 diabetes .</brief_summary>
	<brief_title>A Trial Investigating Total Exposure NN5401 ( Insulin Degludec/Insulin Aspart ) Children , Adolescents Adult Subjects With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>Type 1 diabetes mellitus ( diagnose clinically ) least 12 month Body mass index child : 15.020.0 kg/m^2 ( inclusive ) , adolescent : 18.028.0 kg/m^2 ( inclusive ) adult maximum 30.0 kg/m^2 Subject donate blood plasma past month , 500 mL within 3 month prior screen Not able willing refrain smoking inpatient period Female childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>